A High Frequency of Candida auris Blood Stream Infections in Coronavirus Disease 2019 Patients Admitted to Intensive Care Units, Northwestern India: A Case Control Study.
Ekadashi RajniAshutosh SinghBansidhar TaraiKusum JainRavi ShankarKalpana PawarVedprakash MamoriaAnuradha ChowdharyPublished in: Open forum infectious diseases (2021)
Secondary bacterial infections have been a concern with the use of tocilizumab. In this cohort of critically ill COVID-19 patients, tocilizumab was associated with the development of candidemia. Surveillance of antifungal resistance is warranted to prevent transmission of multidrug-resistant strains of nosocomial yeasts in COVID-19 hospitalized patients.
Keyphrases
- coronavirus disease
- high frequency
- multidrug resistant
- transcranial magnetic stimulation
- rheumatoid arthritis
- sars cov
- candida albicans
- intensive care unit
- acinetobacter baumannii
- juvenile idiopathic arthritis
- rheumatoid arthritis patients
- respiratory syndrome coronavirus
- public health
- escherichia coli
- klebsiella pneumoniae
- drug resistant
- gram negative
- disease activity
- methicillin resistant staphylococcus aureus
- staphylococcus aureus